~~<i id='B125C89B34'><strike id='B125C89B34'><tt id='B125C89B34'><pre id='B125C89B34'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

comprehensive

author：Wikipedia 2025-09-02 22:24:36 - browse：27414

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Flu vaccine offering decent levels of protection this winter, new data show

leisure time

hotspot

focus

hotspot

knowledge

explore

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

WSS

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pfizer highlights cancer drugs it thinks could reignite investor interest

How to fix the rural physician shortage in the U.S.

How to fix the rural physician shortage in the U.S.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Apple is now the first public company to be valued at $3 trillion

leisure time

comprehensive

leisure time

The high cost of giving birth even with insurance

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

DIEP, the 'gold standard' of breast reconstruction, is under threat

Virginia high school admissions case could be legal follow

Apple is now the first public company to be valued at $3 trillion

Virginia high school admissions case could be legal follow

Psychedelics group wrestles with new pharma identity

Medical records are filled with copy

Tori Bowie and the unacceptable rates of Black maternal death

Jerome Adams on the need for new antivirals for Covid

hotspot

International team creates first chimeric human

Obesity now affects over 1 billion people worldwide, study finds

Biotech companies concerned about China biosecurity crackdown

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

United colonoscopy coverage change 'may cost lives,' doctors say

Bright Health sells Medicare Advantage business to Molina

focus

hotspot

knowledge

explore